POMC and neoplasm: In this frame, the Tg:Pomc-Pttg model has been used to evaluate the efficacy of R-roscovitine, a cyclin-dependent kinase (CDK) inhibitor, which showed a strong activity in suppressing ACTH expression, inducing senescence in corticotroph tumor cells, and downregulating cyclin E [103].